Strattera, or atomoxetine, is a drug used to treat Attention Deficit with Hyperactivity Disorder (ADHD) in teens, children, and adults. Strattera should not be taken by people who are on anti-depressants or who have been diagnosed with narrow angle glaucoma.
The serious risks of taking Strattera include an increase in suicidal thoughts or actions, liver damage, weight loss or slowed growth, and impaired motor skills. The more minor side effects of taking Strattera include, for children, upset stomach, decreased appetite, nausea or vomiting, dizziness, tiredness, or mood swings. Adults have a different list of side effects including constipation, dry mouth, nausea, decreased appetite, dizziness, problems sleeping, sexual side effects, problems urinating, and menstrual cramps.
In September 2005, the FDA issued instructions for a change in Strattera's label. It was revised to include warnings concerning the increased risk of thoughts of suicide or suicide attempts in teens and children.